Product Description
DA-9701, a novel prokinetic agent, stimulates gastric emptying and modulates visceral hypersensitivity in vivo and in human studies. This study was conducted to compare the efficacy of DA-9701 with a conventional PPI in mono or combination therapy in patients with FD. (Sourced from: https://pubmed.ncbi.nlm.nih.gov/26811504/)
Mechanisms of Action: D2 Antagonist, 5-HT4 Agonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Korea
Approved Indications: None
Known Adverse Events: None
Company: Dong-A
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 4: Parkinson's Disease|Dyspepsia|Healthy Volunteers
Phase 3: Laryngopharyngeal Reflux|Gastroesophageal Reflux
Phase 2: Dyspepsia
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT07096921 |
PC25MIDI0023 | N/A |
Active, not recruiting |
Dyspepsia |
2026-03-19 |
2025-08-01 |
Primary Endpoints|Treatments |
|
NCT04350346 |
NCT04350346 | N/A |
Unknown status |
Cholelithiasis|Dyspepsia|Gallstones|Cholecystolithiasis |
2021-09-01 |
2022-09-03 |
||
NCT02162316 |
HyFu | N/A |
Unknown status |
Gastritis|Dyspepsia |
2015-06-01 |
2019-03-20 |
||
NCT02151708 |
Evaluation Using MRI Method | N/A |
Unknown status |
Dyspepsia |
2015-02-01 |
2019-03-20 |
Treatments |
|
NCT02091635 |
Evaluation Using MRI Method | N/A |
Completed |
Dyspepsia |
2013-10-01 |
2019-03-20 |
Treatments |
|
NCT02365701 |
Moti_FD_II | P2 |
Completed |
Dyspepsia |
2018-02-01 |
16% |
2019-05-22 |
Patient Enrollment|Primary Completion Date|Start Date|Study Completion Date|Treatments|Trial Status |
NCT01669772 |
DA-9701 trial | P2 |
Completed |
Dyspepsia |
2013-02-01 |
2019-03-19 |
Treatments |
|
NCT02533349 |
NCT02533349 | P3 |
Unknown status |
Gastroesophageal Reflux|Laryngopharyngeal Reflux |
2016-12-01 |
2019-03-20 |
Treatments |
|
NCT02775591 |
PASS-GI | P4 |
Completed |
Parkinson's Disease|Dyspepsia |
2018-06-01 |
2019-03-29 |
Patient Enrollment|Treatments|Trial Status |
|
NCT03022201 |
B-1210/173-006 | P4 |
Completed |
Parkinson's Disease |
2016-05-01 |
2019-03-21 |
Treatments |
|
NCT01817465 |
DA9701_PPI_IV | P4 |
Completed |
Dyspepsia |
2014-03-01 |
2019-03-19 |
Treatments |
|
NCT01719575 |
DA-9701 | P4 |
Completed |
Healthy Volunteers |
2012-11-01 |
2019-03-19 |
Treatments |